8th Nov 2007 17:56
GlaxoSmithKline PLC08 November 2007 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically andprovided to an RIS. Date: 8 November 2007 Name of applicant: GlaxoSmithKline plc Name of scheme: GlaxoSmithKline Share Option Plan - Ordinary Shares Period of return: From: 1 June 2007 To: 7 November 2007 Balance of unallotted securities under scheme(s) from -2,016,067previous return: Plus: The amount by which the block scheme(s) has been 5,000,000increased since the date of the last return (if anyincrease has been applied for): Less: Number of securities issued/allotted under 493,671scheme(s) during period (see LR3.5.7G): Equals: Balance under scheme(s) not yet issued/allotted 2,490,262at end of period: Name of contact: Victoria Whyte Telephone number of contact: 020 8047 5000 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically andprovided to an RIS. Date: 8 November 2007 Name of applicant: GlaxoSmithKline plc Name of scheme: GlaxoSmithKline Share Option Plan - ADS Period of return: From: 1 June 2007 To: 7 November 2007 Balance of unallotted securities under scheme(s) from -25,762,318previous return: Plus: The amount by which the block scheme(s) has been 32,000,000increased since the date of the last return (if anyincrease has been applied for): Less: Number of securities issued/allotted under 3,628,546scheme(s) during period (see LR3.5.7G): Equals: Balance under scheme(s) not yet issued/allotted 2,609,136at end of period: Name of contact: Victoria Whyte Telephone number of contact: 020 8047 5000 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically andprovided to an RIS. Date: 8 November 2007 Name of applicant: GlaxoSmithKline plc Name of scheme: Glaxo Wellcome UK Share Option Scheme Period of return: From: 1 June 2007 To: 7 November 2007 Balance of unallotted securities under scheme(s) from 5,210,158previous return: Plus: The amount by which the block scheme(s) has been 0increased since the date of the last return (if anyincrease has been applied for): Less: Number of securities issued/allotted under 90,408scheme(s) during period (see LR3.5.7G): Equals: Balance under scheme(s) not yet issued/allotted 5,119,750at end of period: Name of contact: Victoria Whyte Telephone number of contact: 020 8047 5000 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically andprovided to an RIS. Date: 8 November 2007 Name of applicant: GlaxoSmithKline plc Name of scheme: Glaxo Wellcome International Share Option Scheme Period of return: From: 1 June 2007 To: 7 November 2007 Balance of unallotted securities under scheme(s) from 13,582,536previous return: Plus: The amount by which the block scheme(s) has been 0increased since the date of the last return (if anyincrease has been applied for): Less: Number of securities issued/allotted under 315,380scheme(s) during period (see LR3.5.7G): Equals: Balance under scheme(s) not yet issued/allotted 13,267,156at end of period: Name of contact: Victoria Whyte Telephone number of contact: 020 8047 5000 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically andprovided to an RIS. Date: 8 November 2007 Name of applicant: GlaxoSmithKline plc Name of scheme: Glaxo Group Limited Share Option Scheme Period of return: From: 1 June 2007 To: 7 November 2007 Balance of unallotted securities under scheme(s) from -679previous return: Plus: The amount by which the block scheme(s) has been 679increased since the date of the last return (if anyincrease has been applied for): Less: Number of securities issued/allotted under 0scheme(s) during period (see LR3.5.7G): Equals: Balance under scheme(s) not yet issued/allotted 0at end of period: Name of contact: Victoria Whyte Telephone number of contact: 020 8047 5000 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically andprovided to an RIS. Date: 8 November 2007 Name of applicant: GlaxoSmithKline plc Name of scheme: Glaxo Wellcome 1999 Share Option Plan Period of return: From: 1 June 2007 To: 7 November 2007 Balance of unallotted securities under scheme(s) from 1,040,000previous return: Plus: The amount by which the block scheme(s) has been 0increased since the date of the last return (if anyincrease has been applied for): Less: Number of securities issued/allotted under 0scheme(s) during period (see LR3.5.7G): Equals: Balance under scheme(s) not yet issued/allotted 1,040,000at end of period: Name of contact: Victoria Whyte Telephone number of contact: 020 8047 5000 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically andprovided to an RIS. Date: 8 November 2007 Name of applicant: GlaxoSmithKline plc Name of scheme: SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares Period of return: From: 1 June 2007 To: 7 November 2007 Balance of unallotted securities under scheme(s) from 241,549previous return: Plus: The amount by which the block scheme(s) has been 0increased since the date of the last return (if anyincrease has been applied for): Less: Number of securities issued/allotted under 37,307scheme(s) during period (see LR3.5.7G): Equals: Balance under scheme(s) not yet issued/allotted 204,242at end of period: Name of contact: Victoria Whyte Telephone number of contact: 020 8047 5000 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically andprovided to an RIS. Date: 8 November 2007 Name of applicant: GlaxoSmithKline plc Name of scheme: SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS Period of return: From: 1 June 2007 To: 7 November 2007 Balance of unallotted securities under scheme(s) from 275,420previous return: Plus: The amount by which the block scheme(s) has been 0increased since the date of the last return (if anyincrease has been applied for): Less: Number of securities issued/allotted under 0scheme(s) during period (see LR3.5.7G): Equals: Balance under scheme(s) not yet issued/allotted 275,420at end of period: Name of contact: Victoria Whyte Telephone number of contact: 020 8047 5000 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically andprovided to an RIS. Date: 8 November 2007 Name of applicant: GlaxoSmithKline plc Name of scheme: SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary Shares Period of return: From: 1 June 2007 To: 7 November 2007 Balance of unallotted securities under scheme(s) from -63,812previous return: Plus: The amount by which the block scheme(s) has been 163,812increased since the date of the last return (if anyincrease has been applied for): Less: Number of securities issued/allotted under 0scheme(s) during period (see LR3.5.7G): Equals: Balance under scheme(s) not yet issued/allotted 100,000at end of period: Name of contact: Victoria Whyte Telephone number of contact: 020 8047 5000 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically andprovided to an RIS. Date: 8 November 2007 Name of applicant: GlaxoSmithKline plc Name of scheme: GlaxoSmithKline Savings Related Share Option Scheme Period of return: From: 1 June 2007 To: 7 November 2007 Balance of unallotted securities under scheme(s) from 2,458,702previous return: Plus: The amount by which the block scheme(s) has been 0increased since the date of the last return (if anyincrease has been applied for): Less: Number of securities issued/allotted under 63,706scheme(s) during period (see LR3.5.7G): Equals: Balance under scheme(s) not yet issued/allotted 2,394,996at end of period: Name of contact: Victoria Whyte Telephone number of contact: 020 8047 5000 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline